Literature DB >> 21947489

Effect of the Honan intraocular pressure reducer on intraocular pressure increase following intravitreal injection using the tunneled scleral technique.

Kyu-Seop Kim1, Donghyun Jee.   

Abstract

OBJECTIVE: To determine the effect of the Honan intraocular pressure reducer (HIPR) on the rise in intraocular pressure (IOP) after an intravitreal injection using a tunneled scleral incision.
DESIGN: This was a prospective, comparative, controlled, non-randomized clinical study.
METHODS: Sixty eyes of 60 patients who received intravitreal injections with the tunneled scleral technique were allocated into two groups, one with and one without application of the HIPR. The pre-operative IOP both before and after application of the HIPR, and the IOP immediately postoperative, and at 3 and 10 min postoperatively were evaluated. The vitreous reflux was estimated by measuring the large diameter of the sub-conjunctival bleb formed after intravitreal injection.
RESULTS: The pre-operative IOP in the HIPR group was significantly lower than that in the non-HIPR group following application of the HIPR. The immediate postoperative IOP was significantly lower in the HIPR group than in the non-HIPR group. The IOP at 10 min postoperatively was lower in the HIPR group than in the non-HIPR group. There was no difference in the amount of vitreous reflux between the HIPR and the non-HIPR groups.
CONCLUSION: The use of the HIPR reduces the IOP after an intravitreal injection using the tunneled scleral technique. However, the HIPR does not appear to affect a reduction in the vitreous reflux.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947489     DOI: 10.1007/s10384-011-0088-1

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  35 in total

1.  The effect of external ocular compression on intraocular pressure following retrobulbar anesthesia.

Authors:  D A Palay; R D Stulting
Journal:  Ophthalmic Surg       Date:  1990-07

2.  Intravitreal injection of triamcinolone acetonide and intraocular pressure.

Authors:  Maria Concepcion Hernaez-Ortega; Enrique Soto-Pedre
Journal:  Acta Ophthalmol       Date:  2008-09       Impact factor: 3.761

3.  Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.

Authors:  Matthew S Benz; Thomas A Albini; Eric R Holz; Rohit R Lakhanpal; Andrew C Westfall; Mohan N Iyer; Petros E Carvounis
Journal:  Ophthalmology       Date:  2006-05-02       Impact factor: 12.079

4.  Portable tonometers: a clinical comparison of applanation and indentation devices.

Authors:  G F Chiara; L P Semes; J W Potter; G R Cutter; W R Tucker
Journal:  J Am Optom Assoc       Date:  1989-02

5.  Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.

Authors:  Max P C Frenkel; Shamim A Haji; Ronald E P Frenkel
Journal:  Arch Ophthalmol       Date:  2010-12

Review 6.  Bevacizumab (Avastin) for the treatment of ocular disease.

Authors:  Jonathan B Gunther; Michael M Altaweel
Journal:  Surv Ophthalmol       Date:  2009 May-Jun       Impact factor: 6.048

Review 7.  A systematic review on the effect of bevacizumab in exudative age-related macular degeneration.

Authors:  Jan S A G Schouten; Ellen C La Heij; Carroll A B Webers; Igor J Lundqvist; Fred Hendrikse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-09       Impact factor: 3.117

8.  Tunnelled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort.

Authors:  Pascal Bruno Knecht; Stephan Michels; Veit Sturm; Martina Monika Bosch; Marcel Nico Menke
Journal:  Retina       Date:  2009-09       Impact factor: 4.256

9.  Purulent anterior segment endophthalmitis following paracentesis.

Authors:  B C Joondeph; H C Joondeph
Journal:  Ophthalmic Surg       Date:  1986-02

10.  Effect of the Honan intraocular pressure reducer in sub-Tenon's anesthesia.

Authors:  James H Vallance; Niall Patton; Andrew Ferguson; Harry G Bennett
Journal:  J Cataract Refract Surg       Date:  2004-02       Impact factor: 3.351

View more
  7 in total

1.  A novel method for the measurement of reflux from intravitreal injections: data from 20 porcine eyes.

Authors:  Frank L Brodie; Jason Ruggiero; Devon H Ghodasra; Kian Eftekhari; James Z Hui; Alexander J Brucker; Brian L VanderBeek
Journal:  Curr Eye Res       Date:  2013-11-20       Impact factor: 2.424

2.  Effect of dorzolamide-timolol fixed combination prophylaxis on intraocular pressure spikes after intravitreal bevacizumab injection.

Authors:  Sehnaz Ozcaliskan; Faruk Ozturk; Pelin Yilmazbas; Ozlem Beyazyildiz
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

3.  Reduction of Intraocular Pressure Spikes Due to Intravitreal Bevacizumab Injections by Scleral Indentation with Cotton Swab or Digital Ocular Massage: Innovative Techniques Compared.

Authors:  Raffaele Nuzzi; Simona Scalabrin; Alice Becco
Journal:  Clin Ophthalmol       Date:  2020-08-27

4.  Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length.

Authors:  Andrea Cacciamani; Francesco Oddone; Mariacristina Parravano; Fabio Scarinci; Marta Di Nicola; Giorgio Lofoco
Journal:  Jpn J Ophthalmol       Date:  2012-10-24       Impact factor: 2.447

5.  Ocular decompression with cotton swabs lowers intraocular pressure elevation after intravitreal injection.

Authors:  Ninel Z Gregori; Matthew J Weiss; Raquel Goldhardt; Joyce C Schiffman; Edgardo Vega; Cherrie-Ann Mattis; Wei Shi; Linda Kelley; Vilma Hernandez; William J Feuer
Journal:  J Glaucoma       Date:  2014 Oct-Nov       Impact factor: 2.503

6.  Reducing intraocular-pressure spike after intravitreal-bevacizumab injection with ocular decompression using a sterile cotton swab soaked in proparacaine 0.5%: A quasi-experimental study.

Authors:  Naveed A Qureshi; Hassan Mansoor; Sabihuddin Ahmad; Sarah Zafar; Muhammad Asif
Journal:  Taiwan J Ophthalmol       Date:  2016-04-19

Review 7.  The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review.

Authors:  Edith Poku; John Rathbone; Ruth Wong; Emma Everson-Hock; Munira Essat; Abdullah Pandor; Allan Wailoo
Journal:  BMJ Open       Date:  2014-07-17       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.